Top Facts You Didn’t Know About Dermatologicals Market by 2026


The global dermatologicals market accounted for $15,563 million in 2018 and is expected to reach $36,205 million by 2026, registering a CAGR of 10.9% from 2019 to 2026. Dermatologicals are medicinal preparations used to treat patients suffering from skin disorders. These preparations are used to treat conditions such as psoriasis, acne, and rosacea. Moreover, there are different types of dermatological formulations available in the market such as topical, and oral. Furthermore, skin disorders are different from each other and therefore, require different treatment options. For instance, disorders such as psoriasis require the use of parenteral dermatological preparations for treatment. In addition, these preparations are mostly available over-the-counter. However, some of the preparations are also prescribed by physicians.

Some of the key players of Dermatologicals Market:

Bayer AG, Johnson & Johnson, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca, Galderma S.A., Amgen Inc., AbbVie Inc., Merck KGaA


Request for Sample Copy of this report





Segmentation by Drug type:

Prescription-Based Drugs and Over-the-Counter Drugs

Segmentation by Route of Administration:

Topical, Oral, and Parenteral Administration

Comments

Popular posts from this blog

Latest Innovation Knocking-in Luxuries Industry

Urgent Care Centers Market

Future Scope for Deep Sea Exploration Robot Industry